Without politics, medicine quickly reaches its limits. This realization led Professor Detlev Ganten to launch the World Health Summit in 2009 – just in time for the 300th anniversary of the Charité – Universitätsmedizin Berlin. Since then, the goal…
Biologist Peter Albiez started his career at Pfizer in 1996 as a pharmaceuticals consultant. Following management positions in sales and marketing, he took over the management of Pfizer's sales organization in 2006. In 2009, he was appointed managing…
Today, most dental implants are inserted with an adapter that is directly screwed to the implant. After insertion, the fixing screw has to be carefully unlocked inside the oral cavity to remove the adapter from the implant. This…
Optical microscopy is an indispensable tool for biomedical research. Yet, the same structures that make biological samples interesting to study under a microscope (such as cells, vasculature and subcellular organelles) scatter light and…
Berlin, September 2018. TissUse has signed a collaboration agreement with Bayer to develop a highly innovative liver-endocrine tissues assay using TissUse’s Multi-Organ-Chip (MOC) technology.
Under the terms of the collaboration agreement, TissUse…
In August 2018, two CAR T cell therapeutics obtained marketing authorization from the European Commission. They provide efficacious treatment options for patients suffering from certain forms of leukemia and who have not responded to other treatment…
On Saturday, the 8th of September 2018, the awards gala of the "Großer Preis des Mittelstandes 2018" took place in the "International Congress Center" of the Dresden Maritim Hotel. The Berlin-based laboratory instrument manufacturer KNAUER…
A tiny change in the very flexible segments of some proteins is enough to trigger rare disorders such as Glut1 deficiency syndrome. A study published in Cell found that other genetic disorders might be traced back to the same origin.
Researchers from Charité – Universitätsmedizin Berlin and the Zuse Institute Berlin have developed a new generation of pain medications. The researchers used computer simulations to develop new opioids that will only work at sites affected by injury…
Investment in the German CRO, specialized in the preclinical assessment of new anticancer drugs, strengthens Citoxlab’s pharmacology portfolio, which will benefit from many synergies with preclinical safety and biomarkers services already provided…
